Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 373 clinical trials
Featured trial
Kidney Disease in Type 2 Diabetics

Kidney Disease in Type 2 Diabetics

  • 1358 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events

A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events

  • 321 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Diabetic Neuropathy in Type 1 and 2 Diabetics

Diabetic Neuropathy in Type 1 and 2 Diabetics

  • 2992 views
  • 25 Mar, 2021
  • 1 location
Hydration to Optimize Metabolism (H2O-metabolism)

This study evaluates hydration (1.5 L of water daily during 1 year) in the lowering of blood glucose concentration in adults with signs of dehydration (elevated levels of the vasopressin marker copeptin and high urine osmolality). Half of participants will in addition to lifestyle advice receive extra water on top …

Accepts healthy volunteers
  • 8 views
  • 02 Mar, 2022
  • 1 location
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

The study is a prospective randomized study to examine the effects of exposure to dulaglutide on the prevention of stress-hyperglycemia and the metabolic inflammatory response in the

  • 0 views
  • 02 Aug, 2021
  • 3 locations
Evaluation of OxxyneaGS in Acute Glycemic Regulation on Light Hyperglycemic Subjects

This study aims to evaluate and select the best combination of polyphenol and white kidney bean ingredients in the acute glycemic modulation after a complete meal by measuring blood glucose and insulin.

Accepts healthy volunteers
  • 0 views
  • 20 Apr, 2022
  • 1 location
Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)

REMD-477 (Volagidemab) is a human anti-glucagon receptor antibody. Its proposed mechanism of action in controlling hyperglycemia is by blocking glucagon receptor (GCGR) signaling. In this way

  • 1 views
  • 25 Nov, 2021
  • 1 location
Effectiveness of CGMS vs. Self-monitoring Blood Glucose (SMBG) in Woman With Gestational Diabetes

to fasting and postprandial hyperglycemia, but can be extended to the glycemic variability that includes both upward (postprandial glucose increments) and downward (interprandial glucose decrements

  • 0 views
  • 29 Oct, 2021
  • 1 location
Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes (MIRE)

insulins mimicking the physiological secretion more closely has led to ultra-fast insulins (fast aspart), allowing for postprandial hyperglycaemia to be better controlled. In Type 1 diabetics treated with

  • 0 views
  • 12 May, 2022
  • 1 location
Effect of Cassia Cinnamon on Arterial Stiffness Parameters in Patients With Type 2 Diabetes Mellitus

hyperglycemia that promotes an increase of cardiovascular risk through the impairment of arterial stiffness and endothelial function, which, in a chronic manner promotes the development of micro and

  • 0 views
  • 26 Feb, 2022
  • 1 location